Zimberelimab (ZIM)
GS-US-624-6376
Phase 2 small_molecule active
Quick answer
Zimberelimab (ZIM) for Lung Cancer is a Phase 2 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcus Biosciences
- Indication
- Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active